Advanced search
Publication Cover
Cogent Medicine Volume 4, 2017 - Issue 1
Journal homepage
7,387
Views
1
CrossRef citations to date
0
Altmetric
Case Report

Risperidone induced amenorrhea and galactorrhea in a case of an adolescent patient

Bradley BrownDepartment of Child and Adolescent Psychiatry, University of Toledo Medical Center, 3000 Arlington Avenue, Toledo, OH43614, USACorrespondence[email protected]
View further author information
,
Navneet PattiDepartment of Child and Adolescent Psychiatry, University of Toledo Medical Center, 3000 Arlington Avenue, Toledo, OH43614, USAView further author information
,
Ryan RosenbergerDepartment of Psychiatry and Behavioral Neuroscience, University of Chicago, 5841 S. Maryland Avenue, Chicago, IL60637, USAView further author information
&
Theodor RaisDepartment of Child and Adolescent Psychiatry, University of Toledo Medical Center, 3000 Arlington Avenue, Toledo, OH43614, USAView further author information
|
Udo SchumacherUniversity Medical Center Hamburg-Eppendorf, Germany
(Reviewing Editor)
Article: 1328819 | Received 19 Dec 2016, Accepted 05 May 2017, Published online: 18 May 2017

References

  • Kim, Y.-K., Kim, L., & Lee, M. S. (1999). Risperidone and associated amenorrhea: A report of 5 cases. The Journal of Clinical Psychiatry, 60, 315–317.10.4088/JCP.v60n0509
  • Kleinberg, D. L., Davis, J. M., De Coster, R., Van Baelen, B., & Brecher, M. (1999). Prolactin levels and adverse events in patients treated with risperidone. Journal of Clinical Psychopharmacology, 19, 57–61.
  • Lee, B.-H., Han, C.-S., Kim, K. H., & Kim, Y. K. (2005). Treatment in risperidone-induced amenorrhoea. International Journal of Psychiatry in Clinical Practice, 9, 29–34.10.1080/13651500510014747
  • Mallikaarjun, S., Salazar, D. E., & Bramer, S. L. (2004). Pharmacokinetics, tolerability, and safety of aripiprazole following multiple oral dosing in normal healthy volunteers. The Journal of Clinical Pharmacology, 44, 179–187.10.1177/0091270003261901
  • Mihara, K., Suzuki, A., Kondo, T., Yasui‐Furukori, N., Ono, S., Otani, K., … Inoue, Y. (2001). Relationship betweenTaq1 A dopamine D2 receptor (DRD2) polymorphism and prolactin response to bromperidol. American Journal of Medical Genetics, 105, 271–274.10.1002/(ISSN)1096-8628
  • Nyberg, S., Eriksson, B., Oxenstierna, G., Halldin, C., & Farde, L. (1999). Suggested minimal effective dose of risperidone based on PET-measured D2 and 5-HT2A receptor occupancy in schizophrenic patients. American Journal of Psychiatry, 156, 869–875.
  • Sachar, E. J., Gruen, P. H., Altman, N., Halpern, F. S., & Frantz, A. G. (1976). Use of neuroendocrine techniques in psychopharmacological research. In E. J. Sachar (Ed.), Hormones, behavior, and psychopathology (pp. 161–161). New York, NY: Raven Press.
  • Spina, E., DʼArrigo, C., Migliardi, G., Morgante, L., Zoccali, R., Ancione, M., & Madia, A. (2004). Plasma risperidone concentrations during combined treatment with sertraline. Therapeutic Drug Monitoring, 26, 386–390.10.1097/00007691-200408000-00008
  • Young, R. M., Lawford, B. R., Barnes, M. Burton, S. C. Ritchie, T. Ward, W. K., & Noble, E. P. (2004). Prolactin levels in antipsychotic treatment of patients with schizophrenia carrying the DRD2*A1 allele. The British Journal of Psychiatry, 185, 147–151.10.1192/bjp.185.2.147

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.